These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 19105626)

  • 1. STD-NMR used to elucidate the fine binding specificity of pathogenic anti-ganglioside antibodies directly in patient serum.
    Houliston RS; Jacobs BC; Tio-Gillen AP; Verschuuren JJ; Khieu NH; Gilbert M; Jarrell HC
    Biochemistry; 2009 Jan; 48(2):220-2. PubMed ID: 19105626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, specificity and functionality of anti-ganglioside antibodies in neuropathy associated with IgM monoclonal gammopathy.
    Stork AC; Jacobs BC; Tio-Gillen AP; Eurelings M; Jansen MD; van den Berg LH; Notermans NC; van der Pol WL
    J Neuroimmunol; 2014 Mar; 268(1-2):89-94. PubMed ID: 24529728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.
    Mauri L; Casellato R; Ciampa MG; Uekusa Y; Kato K; Kaida K; Motoyama M; Kusunoki S; Sonnino S
    Glycobiology; 2012 Mar; 22(3):352-60. PubMed ID: 21921061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifocal motor neuropathy: association of anti-GM1 IgM antibodies with clinical features.
    Cats EA; Jacobs BC; Yuki N; Tio-Gillen AP; Piepers S; Franssen H; van Asseldonk JT; van den Berg LH; van der Pol WL
    Neurology; 2010 Nov; 75(22):1961-7. PubMed ID: 20962291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.
    Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K
    J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes.
    Houliston RS; Yuki N; Hirama T; Khieu NH; Brisson JR; Gilbert M; Jarrell HC
    Biochemistry; 2007 Jan; 46(1):36-44. PubMed ID: 17198373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
    Tagawa Y; Matsumoto Y; Yuki N
    No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
    Caudie C; Vial C; Petiot P; Bancel J; Lombard C; Gonnaud PM
    Ann Biol Clin (Paris); 2001; 59(5):567-77. PubMed ID: 11602387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies.
    Lopate G; Choksi R; Pestronk A
    Muscle Nerve; 2002 Jun; 25(6):828-36. PubMed ID: 12115971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies.
    Zhang G; Lopez PH; Li CY; Mehta NR; Griffin JW; Schnaar RL; Sheikh KA
    Brain; 2004 May; 127(Pt 5):1085-100. PubMed ID: 14985267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
    Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demyelinating symmetric motor polyneuropathy with high anti-GM1 antibody titer: do we need to split?
    Galassi G
    Muscle Nerve; 2011 Jul; 44(1):147-8; author reply 148. PubMed ID: 21660986
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors affecting the fine specificity and sensitivity of serum antiganglioside antibodies in ELISA.
    Ravindranath MH; Ravindranath RM; Morton DL; Graves MC
    J Immunol Methods; 1994 Mar; 169(2):257-72. PubMed ID: 7510761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of immunoblotting and ELISA for detection of anti-ganglioside antibodies in children with Guillain-Barre syndrome.
    Bonyadi MR; Barzegar M; Badalzadeh R; Hashemilar M
    Iran J Immunol; 2010 Jun; 7(2):117-23. PubMed ID: 20574125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope mapping of gibberellin to the anti-gibberellin A(4) monoclonal antibody by saturation transfer difference NMR spectroscopy.
    Murata T; Hemmi H; Nakajima M; Yoshida M; Yamaguchi I
    Biochem Biophys Res Commun; 2003 Aug; 307(3):498-502. PubMed ID: 12893249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M; Suzuki S; Takada K; Kusunoki S
    J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.